We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$254M
AUM Growth
+$22.2M
Cap. Flow
+$5.01M
Cap. Flow %
1.97%
Top 10 Hldgs %
45.13%
Holding
116
New
12
Increased
26
Reduced
50
Closed
24

Top Buys

Rank Stock Value
1
LENZ
LENZ Therapeutics
LENZ
+$20.9M
2
BOLD
Boundless Bio
BOLD
+$12.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$3.72M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.08M
5
PGNY icon
Progyny
PGNY
+$2.87M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.69M
2
EWTX icon
Edgewise Therapeutics
EWTX
+$3.59M
3
ANNX icon
Annexon
ANNX
+$2.96M
4
FDMT icon
4D Molecular Therapeutics
FDMT
+$2.89M
5
VERA icon
Vera Therapeutics
VERA
+$2.82M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LENZ
1
LENZ Therapeutics
LENZ
$162M
$23.9M 9.38%
1,068,675
+1,005,557
+1,593% +$20.9M
LLY icon
2
Eli Lilly
LLY
$1.05T
$20M 7.85%
25,665
-900
-3% -$641K
BOLD
3
Boundless Bio
BOLD
$55.7M
$12.2M 4.79%
+855,875
New +$12.2M
UNH icon
4
UnitedHealth
UNH
$387B
$11.5M 4.51%
23,175
+4,250
+22% +$2.16M
MRK icon
5
Merck
MRK
$315B
$11.4M 4.49%
86,500
+7,000
+9% +$863K
ABT icon
6
Abbott
ABT
$175B
$7.98M 3.14%
70,248
+1,250
+2% +$143K
JNJ icon
7
Johnson & Johnson
JNJ
$609B
$7.57M 2.98%
47,850
-6,000
-11% -$955K
MLYS icon
8
Mineralys Therapeutics
MLYS
$2.39B
$7.13M 2.8%
552,256
-53,350
-9% -$659K
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.9B
$6.81M 2.68%
7,075
+3,240
+84% +$3.08M
ABBV icon
10
AbbVie
ABBV
$450B
$6.41M 2.52%
35,200
-11,100
-24% -$1.91M
BSX icon
11
Boston Scientific
BSX
$65.4B
$5.92M 2.33%
86,476
-5,000
-5% -$321K
TMO icon
12
Thermo Fisher Scientific
TMO
$198B
$5.82M 2.29%
10,015
+1,000
+11% +$561K
PFE icon
13
Pfizer
PFE
$143B
$5.26M 2.07%
189,400
– –
AMGN icon
14
Amgen
AMGN
$198B
$4.57M 1.8%
16,085
-12,600
-44% -$3.69M
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$11.5B
$4.51M 1.77%
51,640
+1,570
+3% +$141K
DXCM icon
16
DexCom
DXCM
$29.6B
$4.49M 1.77%
32,400
+3,000
+10% +$377K
DHR icon
17
Danaher
DHR
$144B
$4.43M 1.74%
17,725
+2,750
+18% +$671K
ZBH icon
18
Zimmer Biomet
ZBH
$17.6B
$3.93M 1.54%
+29,750
New +$3.72M
ARGX icon
19
argenx
ARGX
$53.8B
$3.66M 1.44%
9,307
-720
-7% -$279K
IQV icon
20
IQVIA
IQV
$34.4B
$3.57M 1.4%
14,100
-2,500
-15% -$584K
MDT icon
21
Medtronic
MDT
$106B
$3.32M 1.3%
38,051
-2,000
-5% -$171K
PODD icon
22
Insulet
PODD
$11.4B
$3.1M 1.22%
18,100
+5,150
+40% +$960K
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$123B
$3.01M 1.18%
7,210
-2,009
-22% -$849K
CYTK icon
24
Cytokinetics
CYTK
$10.9B
$2.99M 1.17%
42,583
+35,570
+507% +$2.75M
PGNY icon
25
Progyny
PGNY
$2.5B
$2.9M 1.14%
+76,000
New +$2.87M
1
2 3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sectoral Asset Management held 116 positions worth $254M, up 9.5% from $232M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sectoral Asset Management's Q1 2024 filing shows 12 new, 26 increased, 50 reduced and 24 closed positions. Its largest new stake was Boundless Bio: 855,875 shares worth $12.2M. The largest sale was Amgen, an estimated $3.69M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

  • Sectoral Asset Management's largest Q1 2024 buy was Boundless Bio: 855,875 shares worth $12.2M.
  • Sectoral Asset Management added most to LENZ Therapeutics in Q1 2024, an estimated $20.9M increase.
  • Sectoral Asset Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $3.69M.
  • Sectoral Asset Management fully exited Edgewise Therapeutics in Q1 2024, selling an estimated $3.59M.
  • Sectoral Asset Management's ten largest holdings make up 45% of its $254M portfolio in Q1 2024.
  • Sectoral Asset Management opened 12 new positions and closed 24 in Q1 2024.
  • Sectoral Asset Management's portfolio value rose 9.5% quarter-over-quarter to $254M.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.